Methods of producing adalimumab
US-9284371-B2 · Mar 15, 2016 · US
US10227559B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10227559-B2 |
| Application number | US-201515302488-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 7, 2015 |
| Priority date | Apr 10, 2014 |
| Publication date | Mar 12, 2019 |
| Grant date | Mar 12, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a compounded cell culture medium powder formulation comprising: a basal medium powder and a cell culture media supplement, wherein the cell culture media supplement comprises and one or more salts; one or more growth factors; one or more inorganic ions; an amino acid supplement comprising one or more of asparagine, glutamine, histidine, and serine; one or more buffers; and one or more anti-foaming agents. The invention further provides methods of making a compounded cell culture medium powder formulation methods of making a cell culture medium for growing mammalian cells and methods of producing a protein of interest by culturing cells in the cell culture medium and isolating the protein of interest.
Opening claim text (preview).
What is claimed is: 1. A method of making a compounded cell culture medium powder formulation for growing mammalian cells, comprising: combining a basal medium powder having the following components at the following concentrations upon hydration: i) 0.0003-0.003 g/L biotin; ii) 0.035-0.33 g/L calcium chloride; iii) 0.003-0.03 g/L choline chloride; iv) 0.0002-0.002 g/L cyanocobalamin (B 12); v) 1-10 g/L D-mannose; vi) 0.001-0.01 g/L D-calcium pantothenate; vii) 0.3-3.0 g/L dextrose (anhydrous); viii) 0.00003-0.0003 g/L DL-alpha-lipoic acid; ix) 0.00001-0.00015 g/L ferric nitrate; x) 0.00005-0.0015 g/L ferrous sulfate; xi) 0.001-0.01 g/L folic acid; xii) 0.007-0.20 g/L glycine; xiii) 0.001-0.01 g/L hypoxanthine 2Na; xiv) 0.005-0.05 g/LI-inositol; xv) 0.003-0.03 g/L L-alanine; xvi) 0.08-1.4 /L L-arginine; xvii) 0.006-0.16 g/L L-asparagine; xviii) 0.005-0.10 g/L L-aspartic acid; xix) 0.005-0.05 g/L L-cysteine HCl; xx) 0.02-0.2 g/L L-cystine 2HCl; xxi) 0.005-0.15 g/L L-glutamic acid (anhydrous); xxii) 0.02-1.5 g/L L-glutamine; xxiii) 0.0003-0.003 g/L L-glutathione; xxiv) 0.02-0.2 g/L L-histidine HCl; xxv) 0.03-0.9 g/L L-isoleucine; xxvi) 0.03-0.9 g/L L-leucine; xxvii) 0.05-1.5 g/L L-lysine; xxviii) 0.01-0.3 g/L L-methionine; xxix) 0.02-0.6 g/L L-phenylalanine; xxx) 0.008-0.25 g/L L-proline; xxxi) 0.009-0.25 g/L L-serine; xxxii) 0.03-0.9 g/L L-threonine; xxxiii) 0.006-0.16 g/L L-tryptophan; xxxiv) 0.02-0.9 g/L L-tyrosine 2Na; xxxv) 0.03-0.9 g/L L-valine; xxxvi) 0.01-0.18 g/L magnesium chloride; xxxvii) 0.02-0.12 g/L magnesium sulfate anhydrous; xxxviii) 0.001-0.01 g/L niacinamide; xxxix) 0.0005-0.005 g/L O-phoshphoryl-ethanolamine; xl) 0.1-1.0 g/L potassium chloride; xli) 0.00002-0.0002 g/L putrescine 2HCl; xlii) 0.001-0.01 g/L pyridoxal HCl; xliii) 0.00001-0.0001 g/L pyridoxine HCl; xliv) 0.0001-0.001 g/L riboflavin; xlv) 2.0-15 g/L sodium chloride; xlvi) 0.01-0.2 g/L sodium phosphate monobasic; xlvii) 0.02-0.2 g/L sodium phosphate dibasic anhydrous; xlviii) 0.015-0.15 g/L sodium pyruvate; xlix) 0.001-0.01 g/L thiamine HCl; l) 0.0001-0.001 g/L thymidine; li) 0.00006-0.0015 g/L zinc sulfate; lii) 0.0000003-0.000006 g/L cupric sulfate; liii) 0.0000005-0.000008 g/L selenium dioxide; liv) 0.00001-0.0001 g/L linoleic acid; lv) 0.0001-0.001 g/L beta-mercaptoethanol; lvi) 0.0003-0.005 g/L ethanolamine; with basal media supplement powder having the following components at the following concentrations upon hydration: a) 0.5-5 g/L magnesium chloride; b) 0.5-15 mg/mL insulin; c) one or more additional trace metals selected from the group consisting of: 0.0005-0.01 mg/L ammonium molybdate tetrahydrate, 0.0001-0.01 mg/L chromium potassium sulfate dodecahydrate, 0.001-0.125 mg/L cupric sulfate pentahydrate, 0.001-0.1 mg/L of litium chloride (anhydrous) 0.00004-0.004 mg/L manganese sulfate hydrate, and 0.04-4.2 mg/L of sodium metasilicate nonahydrate; d) one or more additional amino acid selected from the group consisting of 0.007-0.07 g/L asparagine hydrate, 0.25-2.5 g/L glutamine, 0.5-5 g/L histidine free base, and 0.01-0.1 g/L serine; e) one or more buffers; and f) one or more anti-foaming agents, to make a cell culture medium powder, wherein the cell culture media when hydrated completely dissolves the media components.
Organic phosphate, e.g. beta glycerophosphate · CPC title
Culture media for cell or tissue culture (media for specific animal cell type C12N5/06) · CPC title
Amino acids · CPC title
Sugars · CPC title
Thiols, e.g. mercaptoethanol · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.